
Cedars-Sinai Accelerator
Investments
85Portfolio Exits
6About Cedars-Sinai Accelerator
Cedars-Sinai Accelerator aims to transform the healthcare sector by helping entrepreneurs bring their technology products to market. The company provides a three-month program and offers companies $100,000 in funding. It was founded in 2015 and is based in Los Angeles, California.

Want to inform investors similar to Cedars-Sinai Accelerator about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Cedars-Sinai Accelerator News
Sep 15, 2023
11 Jul 2023 • 2 min read Carlsbad, CA (July 11, 2023) - RCE.ai, an innovative health tech company, has been chosen as one of the new participants in the prestigious Cedars-Sinai Accelerator program. This selection recognizes RCE.ai's groundbreaking advancements in healthcare technology and its potential to transform patient care. The Cedars-Sinai Accelerator, located in Los Angeles, California, is renowned for supporting early-stage companies developing cutting-edge solutions in healthcare. RCE.ai has gained recognition for its novel optical based technology and artificial intelligence (AI) platform, which is intended to empower healthcare providers in delivering patient care through real-time assessment and clinical decision support. By leveraging machine learning algorithms and deep data analysis, RCE.ai enables clinicians to make more informed decisions, optimize workflows, and potentially improve patient outcomes. "We are thrilled to be selected for the Cedars-Sinai Accelerator program," said Atandra Burman, Founder and CEO of RCE.ai. "This opportunity will allow us to collaborate with industry leaders, access valuable resources, and refine our solution to better address the evolving needs of patients and healthcare providers." The inclusion of RCE.ai in the accelerator program highlights the company's potential to revolutionize healthcare delivery and patient management. By integrating RCE's technology into clinical workflows, hospitals and healthcare systems can enhance efficiency, reduce costs, and ultimately improve patient satisfaction. Through the Cedars-Sinai Accelerator program, RCE.ai will have access to a range of resources, including mentorship from leading industry experts, guidance in business development and strategy, as well as connections to Cedars-Sinai's vast network of healthcare professionals. About Cedars-Sinai Accelerator: The Cedars-Sinai Accelerator program transforms healthcare quality, efficiency, and care delivery by helping entrepreneurs bring their innovative technology products to market. This three-month program, based in Los Angeles, California, provides companies with $100,000 in funding, mentorship from more than three hundred leading clinicians and executives, access to Cedars-Sinai, and exposure to a broad network of entrepreneurs and investors. Since 2016, the accelerator has helped dozens of companies transform healthcare delivery and patient care. About RCE.ai: RCE.ai, an AI based med tech company works towards the early detection of heart attacks. We have re-imagined the way cardiac proteins are monitored in the blood using a non-invasive transdermal technique. The instant reporting of one such protein, cardiac Troponin empowers emergency medicine physicians and cardiologists in the early assessment and appropriate risk stratification of patients presenting with chest pain. We currently are conducting clinical studies and undertaking premarket efforts. – 2 min read
Cedars-Sinai Accelerator Investments
85 Investments
Cedars-Sinai Accelerator has made 85 investments. Their latest investment was in equalityMD as part of their Incubator/Accelerator on August 8, 2023.

Cedars-Sinai Accelerator Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
8/2/2023 | Incubator/Accelerator | equalityMD | $0.1M | No | 1 | |
7/16/2023 | Convertible Note | 52 North Health | $0.1M | Yes | 1 | |
7/14/2023 | Convertible Note | Predicta Med | $0.1M | Yes | 1 | |
7/11/2023 | Incubator/Accelerator - II | |||||
5/30/2023 | Convertible Note - II |
Date | 8/2/2023 | 7/16/2023 | 7/14/2023 | 7/11/2023 | 5/30/2023 |
---|---|---|---|---|---|
Round | Incubator/Accelerator | Convertible Note | Convertible Note | Incubator/Accelerator - II | Convertible Note - II |
Company | equalityMD | 52 North Health | Predicta Med | ||
Amount | $0.1M | $0.1M | $0.1M | ||
New? | No | Yes | Yes | ||
Co-Investors | |||||
Sources | 1 | 1 | 1 |
Cedars-Sinai Accelerator Portfolio Exits
6 Portfolio Exits
Cedars-Sinai Accelerator has 6 portfolio exits. Their latest portfolio exit was Optio3 on September 26, 2022.
Cedars-Sinai Accelerator Team
1 Team Member
Cedars-Sinai Accelerator has 1 team member, including former Managing Director, Darren Dworkin.
Name | Work History | Title | Status |
---|---|---|---|
Darren Dworkin | Cedars-Sinai Health Ventures, Summation Health Ventures, Cedars-Sinai, Boston Medical Center, and Unisource Worldwide | Managing Director | Former |
Name | Darren Dworkin |
---|---|
Work History | Cedars-Sinai Health Ventures, Summation Health Ventures, Cedars-Sinai, Boston Medical Center, and Unisource Worldwide |
Title | Managing Director |
Status | Former |